Background Rapid and reliable diagnostic work-up of tuberculosis (TB) remains a major healthcare goal. In particular, discrimination of TB infection from TB disease with currently available diagnostic tools is challenging and time consuming. This study aimed at establishing a standardised blood-based assay that rapidly and reliably discriminates TB infection from TB disease based on multiparameter analysis of TB antigen-reactive CD4+ T-cells acting as sensors for TB stage-specific immune status. Methods 157 HIV-negative subjects with suspected TB infection or TB disease were recruited from local tertiary care hospitals in Berlin (Germany). Peripheral blood mononuclear cells were analysed for CD4+ T-cells reactive to the Mycobacterium tuberculosis antigens purified protein derivative and early secretory antigenic target 6 kDa/culture filtrate protein 10. The activation state of TB antigen-reactive T-cells, identified by surface expression of CD154, was evaluated according to the expression profile of proliferation marker Ki-67 and activation markers CD38 and HLA-DR. Using data from 81 subjects with clinically confirmed TB infection (n=34) or culture-proven pulmonary or extrapulmonary TB disease (n=47), 12 parameters were derived from the expression profile and integrated into a scoring system. Results Using the scoring system, our assay (TB-Flow Assay) allowed reliable discrimination of TB infection from both pulmonary and extrapulmonary TB disease with high sensitivity (90.9%) and specificity (93.3%) as was confirmed by Monte-Carlo cross-validation. Conclusion With low time requirement, ease of sample collection, and high sensitivity and specificity both for pulmonary and extrapulmonary TB disease, we believe this novel standardised TB-Flow Assay will improve the work-up of patients with suspected TB disease, supporting rapid TB diagnosis and facilitating treatment decisions. In a prospective study, a scoring system based on analysis of the activation state of tuberculosis (TB)-specific CD4+ T-cells was developed that allows reliable discrimination of TB infection and TB disease with high sensitivity and specificity https://bit.ly/3EFG4KX
Mycobacterium tuberculosis-specific CD4 T-cell scoring discriminates tuberculosis infection from disease
Andrej Mantei,Tim Meyer,M. Schürmann,C. Beßler,H. Bias,D. Krieger,T. Bauer,P. Bacher,J. Helmuth,H. Volk,D. Schürmann,A. Scheffold,C. Meisel
Published 2022 in European Respiratory Journal
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
European Respiratory Journal
- Publication date
2022-05-26
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
CONCEPTS
- cd154
A surface activation marker used to identify tuberculosis antigen-reactive T-cells in this assay.
Aliases: CD40L
- cd38
An activation marker measured on TB antigen-reactive CD4+ T-cells.
- hla-dr
An activation-associated major histocompatibility complex class II marker measured on TB antigen-reactive CD4+ T-cells.
Aliases: human leukocyte antigen-DR
- scoring system
A parameter-based composite score built from 12 features derived from the T-cell expression profile.
Aliases: score
- tb antigen-reactive cd4+ t-cells
CD4+ T-cells in peripheral blood mononuclear cells that respond to Mycobacterium tuberculosis antigens.
Aliases: TB-reactive CD4 T-cells, tuberculosis antigen-reactive CD4 T-cells
- tb-flow assay
A standardized blood-based assay that analyzes tuberculosis antigen-reactive CD4+ T-cells by multiparameter flow cytometry.
Aliases: TB flow assay
REFERENCES
Showing 1-38 of 38 references · Page 1 of 1
CITED BY
Showing 1-15 of 15 citing papers · Page 1 of 1